tiprankstipranks
Advertisement
Advertisement

BCAX Stock Latest News

Bicara Therapeutics reshapes board for commercialization push
Company AnnouncementsBicara Therapeutics reshapes board for commercialization push
5d ago
8K
BCAX
Jeet Mukherjee Reiterates Buy on Bicara, Maintains $28 Price Target on Differentiated Ficera Profile and Upside Potential
PremiumRatings
Jeet Mukherjee Reiterates Buy on Bicara, Maintains $28 Price Target on Differentiated Ficera Profile and Upside Potential
5d ago
BCAX
Bicara Therapeutics Holds 2026 Annual Stockholder Meeting
PremiumCompany Announcements
Bicara Therapeutics Holds 2026 Annual Stockholder Meeting
2M ago
8K
BCAX
Analyst Reiterates Buy on Bicara, Keeps 12-Month Price Target Unchanged at $42 on Encouraging Ficerafusp Alfa Data
PremiumRatings
Analyst Reiterates Buy on Bicara, Keeps 12-Month Price Target Unchanged at $42 on Encouraging Ficerafusp Alfa Data
2M ago
BCAX
Bicara Highlights Durable Three-Year Data for Ficerafusp Alfa
PremiumCompany Announcements
Bicara Highlights Durable Three-Year Data for Ficerafusp Alfa
2M ago
8K
BCAX
Bicara Therapeutics management to meet with Cantor
PremiumThe FlyBicara Therapeutics management to meet with Cantor
2M ago
BCAX
Bicara Therapeutics Highlights Momentum in Earnings Call
Premium
Company Announcements
Bicara Therapeutics Highlights Momentum in Earnings Call
2M ago
BCAX
Bicara Therapeutics’ Earnings Call Highlights Ficera Momentum
Premium
Company Announcements
Bicara Therapeutics’ Earnings Call Highlights Ficera Momentum
3M ago
BCAX
BCAX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
BCAX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
BCAX
Bicara Therapeutics’ Acquisition Strategy Poses Operational, Financing, and Shareholder Dilution Risks
PremiumCompany Announcements
Bicara Therapeutics’ Acquisition Strategy Poses Operational, Financing, and Shareholder Dilution Risks
3M ago
BCAX
Bicara Therapeutics price target raised to $37 from $36 at Morgan Stanley
PremiumThe Fly
Bicara Therapeutics price target raised to $37 from $36 at Morgan Stanley
3M ago
BCAX
Bicara Therapeutics price target raised to $18 from $16 at Goldman Sachs
PremiumThe Fly
Bicara Therapeutics price target raised to $18 from $16 at Goldman Sachs
3M ago
BCAX
Bicara Therapeutics reports Q1 EPS (93c), consensus (65c)
PremiumThe FlyBicara Therapeutics reports Q1 EPS (93c), consensus (65c)
3M ago
BCAX
Tyler Van Buren Reiterates Buy Rating on Ficera, Citing Strong Phase III Momentum and Best-in-Class Potential in HPV-Negative Head and Neck Cancer
Premium
Ratings
Tyler Van Buren Reiterates Buy Rating on Ficera, Citing Strong Phase III Momentum and Best-in-Class Potential in HPV-Negative Head and Neck Cancer
3M ago
BCAX
Bicara Therapeutics initiated with a Buy at Guggenheim
Premium
The Fly
Bicara Therapeutics initiated with a Buy at Guggenheim
3M ago
BCAX
Bicara Therapeutics initiated with a Buy at Guggenheim
PremiumThe Fly
Bicara Therapeutics initiated with a Buy at Guggenheim
3M ago
BCAX
Bicara Therapeutics’ Earnings Call Highlights Pivotal Pivot
PremiumCompany Announcements
Bicara Therapeutics’ Earnings Call Highlights Pivotal Pivot
4M ago
BCAX
Bicara Therapeutics management to meet with Citizens
PremiumThe Fly
Bicara Therapeutics management to meet with Citizens
4M ago
BCAX
Bicara Therapeutics price target raised to $16 from $11 at Wells Fargo
PremiumThe Fly
Bicara Therapeutics price target raised to $16 from $11 at Wells Fargo
4M ago
BCAX
Buy Rating Backed by Ficerafusp Alfa Milestones and Strong Cash Runway Supporting $42 Target Price
PremiumRatingsBuy Rating Backed by Ficerafusp Alfa Milestones and Strong Cash Runway Supporting $42 Target Price
4M ago
BCAX
Bicara Therapeutics price target raised to $16 from $14 at Goldman Sachs
Premium
The Fly
Bicara Therapeutics price target raised to $16 from $14 at Goldman Sachs
4M ago
BCAX
Morning Movers: Sysco dips following deal to acquire Jetro Restaurant Depot
Premium
The Fly
Morning Movers: Sysco dips following deal to acquire Jetro Restaurant Depot
4M ago
IQ
SR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >